Skip to main content

Ready to start planning your care? Call us at 833-347-1665 to make an appointment.

Memorial Sloan Kettering Cancer Center

Sloan Kettering Institute

  • MSKCC.org Home
  • Find a Researcher
  • Contact Us
  • About Us
  • Research
  • Education & Training
  • News & Events
  • Open Positions
    • MSKCC.org Home
    • Find a Researcher
    • Contact Us
  • Sloan Kettering Institute
  • Research
  • Research Programs
  • Molecular Biology Program
  • The Andrew Koff Lab

Marta Kovatcheva, PhD

Graduate Student
The Andrew Koff Lab
More About The Andrew Koff Lab
Research Overview
Projects
  • Overview
  • The Lab of Cell Cycle Regulation
  • Clinical Implications of SAGA
Publications

Marta Kovatcheva, PhD

Graduate Student
Share
Share
Marta Kovatcheva

Lab Phone

212-639-2354

Email

[email protected]

Dissertation

New roles for old proteins: MDM2 and ATRX drive the transition from quiescence to senescence (2017)

Mentor

Andrew Koff, PhD

Start Year

2010

End Year

2017

Education

University of Toronto

Fellowships

Grayer Fellowship (2012-2013)

Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (2011-2012)

Publications

Kovatcheva M, Klein ME, Tap WD, Koff A. (2017) Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors. Mol Cell Oncol. 5, e1384882. PMCID: PMC5791849. [Available on 2018-11-07]

Klein ME, Kovatcheva M, Davis LE, Tap WD, Koff A. (2018) CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought. Cancer Cell. [Epub ahead of print]

Kovatcheva M, Liao W, Klein ME, Robine N, Geiger H, Crago AM, Dickson MA, Tap WD, Singer S, Koff A. (2017) ATRX is a regulator of therapy induced senescence in human cells. Nat Commun. 8, 386. PMCID: PMC5577318

Kovatcheva M, Liu DD, Dickson MA, Klein ME, O’Connor R, Wilder FO, Socci ND, Tap WD, Schwartz GK, Singer S, Crago AM, Koff A. (2015) MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition. Oncotarget, 6, 8226-43. PMCID: PMC4480747.

Related topics:

Pictured: Marta Kovatcheva & Andrew Koff
Gerster Sloan Kettering Graduate School Awards Fellowships
About Us
About Us
  • Overview
  • Leadership
  • Administration
  • History
  • Contact Us
Research
Research
  • Overview
  • Research programs
  • Research labs
  • Core facilities & resources
Education & Training
Education & Training
  • Overview
  • Postdoctoral training
  • Gerstner Sloan Kettering Graduate School
  • Joint graduate programs
  • Programs for college & high school students
News & Events
News & Events
  • Overview
  • Seminars & events
Open Positions
Open Positions
  • Overview
  • Faculty positions
  • Postdoctoral positions
Memorial Sloan Kettering Cancer Center
  • Communication preferences
  • Cookie preferences
  • Legal disclaimer
  • Privacy policy
  • Public notices
© 2023 Memorial Sloan Kettering Cancer Center
Log in web-44140.prod.hosting.acquia.com